Join
Live feed
·
INSIDERFilingvia Quantisnow
ResMed Inc. logo

Director De Witte Jan sold $121,872 worth of ReMed Common Stock (487 units at $250.25) and covered exercise/tax liability with 76 units of ReMed Common Stock, decreasing direct ownership by 10% to 5,242 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RMD (ResMed Inc.) and more on Quantisnow.